Breaking News
Top News
-
Why Applied Digital (APLD) Is Scaling Its AI Factory Backlog With a New Hyperscaler Lease
-
Why Palantir (PLTR) Is Expanding Its AI Software Footprint at the USDA
-
Why Eva Live (GOAI) Is Drawing Attention After 83% Revenue Growth
-
Why Aeva Technologies (AEVA) Is Expanding Its AI-Powered Smart Infrastructure Deployment
-
Why Brand Engagement Network (BNAI) Is Moving Its Enterprise AI Into Fleet Operations
-
Why CoreWeave (CRWV) Is Strengthening Its AI Cloud Growth Story With Meta
-
Why Rezolve AI (RZLV) Is Expanding Its Commerce AI Platform Through Microsoft Foundry
-
Apple Shares Edge Higher on Strong Results and “Remarkable” Margin Outlook
-
Reddit Shares Jump 17% Premarket as Revenue Strength and EBITDA Growth Outshine Earnings Miss
-
SBI, State Street plan Japan fund venture with low-fee focus
-
How AI is bettering B2B payments
-
MiMedx Group (MDXG) Launches CHORIOFIX Placental Allograft for Complex, Tunneling Wounds
-
Arbutus Biopharma (ABUS): 10 Best Biotech Penny Stocks to Buy in 2026
-
Western Digital Shares Drop Despite Strong Q3 Beat
-
Posco signs US$765m deal for 30% stake in Australian lithium mines
-
Allogene Therapeutics (ALLO) Closes $200.4M Public Offering of Common Stock
-
Target launches new kind of supply chain facility
-
Lexicon Pharma (LXRX), Novo Nordisk (NVO) Initiate Phase 1 Study for Obesity Drug LX9851
-
Here is Why Absci Corp. (ABSI) is One of the Best Biotech Penny Stocks to Buy in 2026
-
ProKidney (PROK) Appoints Greg Madison as CCO to Lead Commercial Strategy for Rilparencel
2026-02-05











